Cannabis Law Report

JANUARY 24, 2022

–(BUSINESS WIRE)–Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced the appointment of Edwin (Ed) Tucker, M.D., Media: Liz Melone. CAMBRIDGE, Mass.–(BUSINESS Goldfinch Bio: Investors: Hannah Deresiewicz.

Clinical Trials 52

Clinical Trials Research and Development Data Medicine 52

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. Commence clinical program in PTSD.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

The Cannigma

JULY 1, 2022

What if most of it is not based on the level of scientific certainty that cannabis marketing teams and media outlets would have us believe? Because of this variability in the plant, and because of a lack of standard methods–like chemical analyses of cannabinoids or terpenes–has led to inconsistent scientific results. Types of Research.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Veriheal

OCTOBER 1, 2020

Amphetamines, barbiturates, cannabis, codeine, ketamine, methylphenidate (Ritalin), synthetic cannabinoids, synthetic cathinones (for example mephedrone, methoxetamine). In 2018, the government was confronted by a media storm that has called for them to act. As a result, the UK proposed medicinal cannabis regulations in 2018. .

Legalization 104

Legalization Oil Medicine Media 104

Alchimia

MARCH 16, 2016

Although a balanced nutrition – and regular brain stimulation – can have protective and preventive effects , we still don’t have any effective treatment for Alzheimer’s disease once it is active. Finally, cannabinoids improve mood, appetite and sleep while reducing stress, anxiety and agressiveness.

Cannabinoids 76

Cannabinoids Research and Development Treatment Patients 76

Cannabis Law Report

SEPTEMBER 24, 2019

Some parents, who have travelled to the Netherlands to buy cannabis medicines, feel the treatment will not help many children because it does not contain THC, which they argue has helped their children. These treatments can be prescribed only by specialist doctors in a limited number of circumstances where other medicines have failed.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Veriheal

AUGUST 12, 2021

million people across the United States , report experiencing improved quality of life and a more restful night’s sleep after consuming the non-psychoactive cannabinoid CBD (cannabidiol). Patients who suffer from epilepsy , which affects some 3.4 CBD, which constitutes a $2,770.8

Epilepsy 66

Epilepsy Pharmaceutical Patients Sleep 66

Cannabis Law Report

OCTOBER 15, 2021

At Kidney Week 2021, Goldfinch Bio will present multiple e-posters, including: The design of TRACTION-2, the ongoing Phase 2 clinical trial evaluating GFB-887 for the treatment of focal segmental glomerulosclerosis (FSGS) and diabetic nephropathy (DN). Media: Liz Melone. CAMBRIDGE, Mass.–(BUSINESS Poster Number: INFO37.

Clinical Trials 52

Clinical Trials Research and Development Data Patients 52

Cannabis Law Report

FEBRUARY 17, 2022

Mycotoxins are contaminants that licensees are required to screen for to uphold public health, safety, and welfare. Mycotoxins are contaminants that licensees are required to screen for to uphold public health, safety, and welfare. There are currently no ISO-accredited Independent Testing Laboratories located on Nantucket.

Marijuana 52

Marijuana Seed-To-Sale Safety Patients 52

Cannabis Law Report

DECEMBER 14, 2021

There are 28 million people suffering from chronic pain in the UK and this range of formulations offers pain doctors the best and most comprehensive selection of cannabinoid treatment options for their patients. Media Lindsay Wilson. media@col-care.com. Investor Lee Ann Evans. Investor Relations. 1.212.271.0915.

Extraction 52

Extraction Patients Medicine Tincture 52

CannaMD

JULY 13, 2020

Due to the federal restrictions on cannabis use, research about marijuana’s safety and effects has been limited. Cannabis concentrates are made by extracting the plant’s cannabinoids to produce a much higher THC concentration, often in the 80% range). These include: Verbal recall (memory). Selective attention. Inhibitory motor control.

THC 69

THC Concentrates Cannabinoids Marijuana 69

The Joint Blog

JULY 25, 2020

Lately, CBD has warranted a huge share of public and media attention for its perceived benefits to health and well-being. FDA is the government agency that ensures the safety and quality of foods, drugs, cosmetics, and other like products marketed in the United States. CBD Legal and Safety Issues An FDA report presented to the U.S.

CBD 33

CBD Clinical Trials Safety Media 33

Cannabis Law Report

MAY 5, 2022

The FDA reviews social media and websites to make its determination. The FDA sets rigorous testing standards to establish a drug’s safety. CBD is a non-impairing cannabinoid found in the cannabis plant, and often present in hemp due to selective breeding. Delta-8 in Food.

Food 52

Food THC CBD Research and Development 52

Cannabis Law Report

JULY 20, 2019

In New Jersey, there are nearly 50,000 registered medical marijuana patients and only six Alternative Treatment Centers (ATCs) currently operating. Ability to meet the overall health needs of qualified patients and safety of the public. Health and safety standards for lab employees. MEDIA CONTACT. Kristin Jordan.

Law 40

Law Marijuana Education Cultivation 40

Alchimia

JANUARY 4, 2016

The three most populated Australian States (Victoria, New South Wales, Queensland) promised to organize studies on the efficiency of cannabis to alleviate terminally ill patients, controlling severe epilepsy in children, as well as for the treatment of side effects of chemotherapy. But on August 17, 2015 a judge has authorized Graciela?s

Marijuana 48

Marijuana Epilepsy Pharmaceutical Chronic Pain 48

Cannabis Law Report

JULY 23, 2019

After using Koi’s products, Thurston was given a random drug test by her employer, which came back positive for cannabinoids. It is important that they conduct medical research into the safety and effectiveness of cannabis products through adequate and well-controlled clinical trials. She lost her job as a result.

Law 40

Law Clinical Trials CBD Edibles 40

Cannabis Law Report

OCTOBER 29, 2021

The primary endpoint of this Phase 1 trial was safety and tolerability. social media: www.igcinc.us / www.igcpharma.com. Based on this study and subject to FDA concurrence the cannabis-based investigational drug IGC-AD1 was generally safe and well-tolerated by the Alzheimer’s trial participants.

Clinical Trials 52

Clinical Trials Research and Development Data Business 52

Project CBD

FEBRUARY 28, 2023

sativa do not naturally contain cannabinoids, but they can become contaminated with CBD from other plant parts during processing. In December 2021, Leafreport, an online CBD resource owned by Empire Media Network, published the results of analyses of 221 CBD products it sent to third-party laboratories for testing. 2 The seeds of C.

CBD 144

CBD Seed-To-Sale Food Access 144

CannaMD

MARCH 8, 2021

Prohibiting a medical marijuana treatment center from dispensing marijuana that exceeds a certain potency of tetrahydrocannabinol [p. Revising a provision relating to the potency of tetrahydrocannabinol in edibles dispensed by a medical marijuana treatment center [p.1, 2, line 32]. 2, line 38]. 1, line 12]. 2, line 26]. 2, line 29].

THC 116

THC Research and Development Treatment Patients 116

Cannabis Law Report

JULY 8, 2021

“Our goal with this study is to enhance the existing treatment’s efficacy through adding CBD to create a new standard of care, potentially improving and extending glioblastoma patients’ quality of life.” Chief Medical Officer, Enveric Biosciences. SOURCE Enveric Biosciences. Related Links.

Treatment 98

Treatment Clinical Trials CBD Patients 98

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. This article analyses media representations of medicinal cannabis in Australian medical publications. Background.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

MARCH 6, 2020

Europe is on the forefront of pharmaceutical development in the growing market for cannabinoid receptor target therapeutics which should bring further attention to our efforts in moving KLS-13019 forward for the treatment of neuropathic pain and other CNS disorders associated with neuroinflammation,” said Dean Petkanas , CEO of Kannalife.

Research and Development 59

Research and Development Marijuana Pharmaceutical Supply Chain 59

SpeedWeed

JULY 19, 2021

The document in question was a 2020 safety study of the vape cartridge additive phytol. Certain vape additives are associated with lung injury, which shows up as cloudy on the left x-ray, and clear after treatment of one suspected VAPI patient in Utah. Show me the safety data. Courtesy University of Utah). Which ones?

Vaping 52

Vaping Terpenes Data Research and Development 52

Kind Meds (Cannabis Education Blog)

DECEMBER 14, 2020

For decades, the media has mistakenly depicted marijuana as a dangerous drug that induces changes in your mental state, causing unethical behavior and criminal tendencies. Hybridization allows for the creation of unique properties to provide more effective, personalized treatment. Research Specific Strains.

Strains 137

Strains Indica Hybrid Sativa 137

Cannabis Law Report

JUNE 4, 2021

there has never been a better time for new treatment options. Our proprietary ranking system takes into account: Social reach (social media, blogs, podcasts, publications, etc.). Through his social media outlets, podcast, blog, and interviews, Tim has educated hundreds of millions of people about psychedelics. Followers.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

The Cannigma

JANUARY 19, 2022

The resulting prejudice can often discourage folks from seeking out medical cannabis as an option, and can even affect state legislature, forcing patients to overcome unnecessary and prohibitive obstacles in order to receive the treatment they need. EG: Definitely. Specific strain names, I learned, really mean nothing.

Patients 83

Patients Compliance Compliance Cannabis 83